🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 ECDC Webinar ➡️ Behavioural Science in Action: Using Behavioural Science to Counteract #AntibioticResistance What can social and #BehaviouralScience teach us about tackling #AMR? 🗓️ Monday 27 January 2025 🕕 15.30-16.30 CET 💻 Online Register: bit.ly/3C1hAQp

Important Covid editorial Science Magazine by Maria Van Kerkhove World Health Organization (WHO) science.org/doi/10.1126/sc…

Kickstart your year with the first REVIVE webinar for 2025! Anna Hirsch & Patrizio Mattei will unpack the importance of chemical synthesis for antimicrobial research & development. 📆 23 January 2025, 17:00-18:30 CET 👉Register now for free: attendee.gotowebinar.com/register/74810…

REVIVE webinar: it's time to register ⌛️ Anna Hirsch & Patrizio Mattei will unpack the importance of chemical synthesis for antimicrobial research & development. 📆 Today, 17:00-18:30 CET 👉Register now for free: attendee.gotowebinar.com/register/74810…

Cutting-edge tools for unveiling the dynamics of plasmid–host interactions dlvr.it/THWXsg

Join us at #ACC2025! Take a deep dive into antimicrobial R&D with sessions on drug discovery, pre and clinical antimicrobial development, and antifungal development pipeline. 📆4 & 5 February, 2025 Free registration 👇 acc-conference.com

Mark your calendars! 🗓️ #ACC2025 is just around the corner! Join us in February for discussions with leading experts in antimicrobial R&D. 4 & 5 February, 2025 Register today for free 👇 acc-conference.com With Breast Cancer

Disappointing results - an example of the challenge in developing good antibacterial vaccines.... Sanofi takes $250M hit after gamble on J&J E. coli vaccine ends in phase 3 failure fiercebiotech.com/biotech/sanofi…

📣📣 Grand Challenge announced 👇🏻: Innovations for Gram-Negative Antibiotic Discovery gcgh.grandchallenges.org/challenge/inno…

Does anticancer therapy directly contribute to antimicrobial resistance? - The Lancet Microbe thelancet.com/journals/lanmi… 👏👏👏 Timothy Miles Rawson

Prof. Hanna Engelberg-Kulka Hebrew University passed away last night. Hanna was an extraordinary, original and brave microbiologist who discovered the first chromosomal #toxin-#antitoxin system in #Escherichia coli. Together with Prof. Gadi Glaser, she named the system #mazEF (which in

Our latest article ‘Global health perspectives on antibacterial drug discovery and the pre-clinical pipeline’ is out Nature Reviews Microbiology ! Read only version accessible here rdcu.be/efmcB

📣Just published: "Global Health Perspectives on Antibacterial Drug Discovery and the Preclinical Pipeline” in Nature Reviews Microbiology ✍️Ursula Theuretzbacher Dr. Ravindra P. Jumde Alan Hennessy Jennifer Cohn Laura Piddock 💙 👉rdcu.be/efmcB

🌍 Exciting news ! 🍄WHO releases its first-ever reports on tests and treatments for fungal infections! 1️⃣ Pipeline analysis on antifungal agents 2️⃣ Landscape analysis of in vitro diagnostics 🔗 Read more shorturl.at/JthQi EU HERA Global Antibiotic R&D Partnership (GARDP) Erin Duffy Journal of Fungi MDPI

New online! The global resistance problem and the clinical antibacterial pipeline nature.com/articles/s4157…

Three million child deaths linked to drug resistance, study shows bbc.com/news/articles/…

Just off Fleet Street is the free museum and crypt of St Bride's with a treasure trove of objects! Read more here: lookup.london/st-brides-cryp…

Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay | Science Translational Medicine science.org/doi/10.1126/sc…

Inside the Tower of London you can find the Valasse Cross, created in the 11th century and supposedly own by Empress Matilda. It's on temporary loan and you can find it inside the Norman Chapel of St John. Read all about it here: lookup.london/valasse-cross-…

🚨 This is Big! New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the appropriate antibiotics because of large gaps in access. Improving access and developing new antibiotics must be a priority, 📖 Read the study 👇